Clinical and Pharmacologic Research

What Clinical and Pharmacologic Research does

WVU Clinical and Pharmacologic Research Center (WVU CPRC) is a contract research organization (CRO) that conducts Phase I and Phase II clinical trials on behalf of pharmaceutical sponsors, with a primary focus on bioequivalence and bioavailability studies comparing generic medications to FDA-approved brand-name drugs. Headquartered in Morgantown, West Virginia, at 733 Chestnut Ridge Road in proximity to the West Virginia University Health Sciences Center, the organization operates as the commercial arm of the WVU Research Corporation and maintains a secondary clinical presence at the WVU Bone Marrow Transplant Unit within Mary Babb Randolph Cancer Center for leukapheresis procedures. The organization is staffed by 51–100 employees and is actively hiring across roles including Clinical Research Coordinator, Clinical Research Nurse, Clinical Trials Physician, Lead Screening Technician, and Quality Control Specialist.

The technology stack supporting trial execution includes clinical research management systems with real-time dashboard data for KPI tracking across IRB submissions, recruitment, and volunteer satisfaction; ECTD and Data Management Systems for regulatory submissions; and validated QC and QMS systems operating within a Good Clinical Practice (GCP) regulatory framework. A phase-gate study approach with rigorous clinical and technical review prior to report submission is designed to ensure data accuracy and reliability. Service offerings encompass end-to-end CRO capabilities — study planning, volunteer recruitment, financial planning and budgeting, regulatory compliance — alongside specialized sub-products including leukapheresis, clinical trial screening (blood/urine collection, vital signs, ECG, drug screening), and participant recruitment campaigns spanning multiple West Virginia counties and adjacent states.

WVU CPRC operates a professional services revenue model funded through multi-year contracts with major pharmaceutical sponsors; revenue figures are not publicly disclosed. The go-to-market is sales-led, with the Center functioning as an intermediary portal between WVU and pharmaceutical companies for collaborative clinical research and partnership expansion. Participant compensation varies by study complexity, ranging from $25 gift cards for screening studies to up to $3,000 for extended outpatient trials. The volunteer base spans healthy adults aged 18+, post-menopausal women, males with hypogonadism, smokers/e-cigarette users, and colorectal cancer screening-eligible populations, with a 95% volunteer repeat-participation rate cited from a 2013 CISCRP report.

Name

Clinical and Pharmacologic Research

Legal name

WVU Clinical and Pharmacologic Research Center

Website

https://wvucprc.com

Company type

Private

Operating status

Operating

Headcount range

51–100 employees

Short description

WVU CPRC is a university-affiliated contract research organization in Morgantown, WV that runs Phase I and Phase II clinical trials for pharmaceutical sponsors, primarily bioequivalence studies comparing generic and brand-name drugs, and recruits healthy volunteers and patient populations across the region.

Ownership category

akta.pro rank

Product category

Clinical Research Services (CRO)

NAICS

Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Clinical Trial Site Operations & Study Coordination (HLAGACAE), Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI)

Keywords

• Clinical trial services
• Contract research organization
• Pharmacokinetic studies
• Generic drug bioequivalence
• Volunteer recruitment for trials

Headquarters

HQ city

Morgantown

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Trial Services for Pharmaceutical Sponsors: WVU CPRC serves as a contract research organization providing clinical trial services to pharmaceutical companies. As the commercial arm of WVU Research Corporation, they conduct paid clinical trials in exchange for sponsor funding. Results help create generic medication options for pharmaceutical companies.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

WVU Clinical and Pharmacologic Research Center is a contract research organization (CRO) that conducts paid Phase I and Phase II clinical trials on behalf of pharmaceutical sponsors, with a primary focus on bioequivalence and pharmacokinetic studies comparing generic medications to FDA-approved brand-name drugs. The center delivers end-to-end trial execution including study planning, volunteer recruitment, screening, dosing, sample collection (including leukapheresis), regulatory submissions, and quality-controlled study report delivery under FDA and Good Clinical Practice oversight.

Product overview

WVU Clinical and Pharmacologic Research Center operates as a contract research organization (CRO) offering Phase I and Phase II clinical trial services. The core offering is clinical research comparing generic to brand-name medications under FDA oversight. Key products include clinical trials research services, CRO services for sponsors (encompassing study planning, volunteer recruitment, and financial planning), Leukapheresis procedures, volunteer recruitment services, dashboard data analytics for KPI tracking, and clinical trial screening services. The center serves as an intermediary portal between WVU and pharmaceutical companies for collaborative clinical research.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Trials Research Services Phase I and Phase II clinical trial services comparing generic to brand-name medications, monitoring how study drugs are absorbed and used by the human body with or without food, conducted under FDA regulatory oversight. Delivered to pharmaceutical sponsors as the core service offering.
• Contract Research Organization (CRO) Services Full-service CRO capabilities offered to pharmaceutical sponsors, including study planning, volunteer recruitment, financial planning and budgeting, regulatory compliance, ECTD data management, and Phase-gate study report submission. Positions the center as a one-stop shop for clinical research needs.
• Leukapheresis Service A continuous sterile procedure that separates white blood cells from donated blood, conducted at the WVU Bone Marrow Transplant Unit (BMTU) at Mary Babb Randolph Cancer Center for medical research purposes. Donations take place in close proximity to Ruby Memorial Hospital.
• Clinical Trial Screening Services Comprehensive screening procedures for prospective clinical trial participants, including blood and urine collection, vital signs, ECG, drug screening, and medical history assessment, used to determine volunteer eligibility for enrollment.

Quantifiable outcome

• 95% of study volunteers who participate in clinical research would participate again

Named customers2 records

Segments6 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Four partnerships are on record, tiered core and flagship.

• Epigenomics, Inc.coreStrategic or Co-development Partner · 15 June 2018WVU CPRC and Epigenomics, Inc. are conducting a blood draw based colorectal cancer clinical research study for qualified participants age 50-75. The test is FDA approved and used in participants who are unwilling or unable to use other screening tests such as colonoscopy or fecal blood tests. Participants receive $25 gift card for participation.
• WVU Research CorporationflagshipStrategic or Co-development PartnerWVU CPRC is the commercial arm of the WVU Research Corporation. They function as an integrated entity of the University with a high degree of operational flexibility to capitalize on market opportunities. Serves as Intermediary portal between WVU and pharma for expansion of collaborative clinical research and partnership.
• WVU Health Sciences CampuscoreStrategic or Co-development PartnerFaculty at WVU Health Sciences campus provide medical and scientific oversight to the Center. Allows for internship opportunities for WVU Pharmacy and Medical Students. Located in close proximity to the WVU HSC campus.
• WVU MedicinecoreStrategic or Co-development PartnerWVU CPRC is in line with the vision and mission of WVU Medicine. WVU Medicine provides affiliated healthcare services and collaborative opportunities for clinical research.

Scale indicators3 records

Recent moves1 record

Expansion highlights4 records

Direct peers

• Celerion: Celerion is a specialized early-phase (Phase I) clinical CRO with deep expertise in bioequivalence, pharmacokinetic, and first-in-human studies — closely mirroring WVU CPRC's core service offering for generic-drug sponsors.
• Novum Pharmaceutical Research Services: Novum is a niche U.S. CRO specializing in bioequivalence and Phase I clinical pharmacology studies for generic drug developers, closely comparable in service mix and target sponsors to WVU CPRC.
• Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-sized global CRO with strong Phase I and bioequivalence capabilities alongside later-phase services, making it directly comparable to CPRC's Phase I/II focus and its stated expansion intent.
• BioPharma Services Inc. BioPharma Services is a specialized clinical CRO focused on bioequivalence and early-phase clinical pharmacology studies, very similar in scale, therapeutic focus, and service mix to WVU CPRC.

Broad incumbents

• Parexel International: Parexel is a global full-service CRO offering Phase I-IV clinical development, biostatistics, and regulatory services — a broad incumbent competing for the same pharma sponsor relationships as CPRC.
• PPD (Thermo Fisher Scientific): PPD, now part of Thermo Fisher Scientific, is one of the largest global CROs offering full Phase I-IV services, site management, and central labs — a broad incumbent competing for the same pharma sponsor budgets as WVU CPRC.
• Charles River Laboratories: Charles River Laboratories is a large nonclinical and clinical CRO with early-phase clinical pharmacology and bioanalytical lab services — overlapping with CPRC's Phase I and lab/screening capabilities.
• IQVIA: IQVIA is the world's largest CRO and life-sciences services firm with end-to-end Phase I-IV capabilities, including major Phase I clinical pharmacology units — a broad incumbent competitor for sponsor contracts.
• ICON plc: ICON plc is a global CRO offering full-service Phase I-IV clinical development and laboratory services following its PRA Health Sciences merger, directly comparable to CPRC's clinical research offering at much larger scale.

Others

• LabConnect: LabConnect provides centralized lab and clinical trial support services including sample management and bioanalytical logistics — an adjacent enabling peer given CPRC's central lab, ECTD data management, and screening workflows.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/wvucprc
• YouTubeyoutube.com/westvirginiau
• Facebookfacebook.com/wvucprc

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Clinical and Pharmacologic Research